Report Detail
Global Encephalitis Vaccine Market Insights, Forecast to 2025
- RnM2652247 |
- 11 June, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds.
It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas.
The global Encephalitis Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Encephalitis Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Encephalitis Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Encephalitis Vaccine in these regions.
This research report categorizes the global Encephalitis Vaccine market by top players/brands, region, type and end user. This report also studies the global Encephalitis Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Liaoning Chengda
Wuhan Institute of Biological
Valneva
Tiantan Biological Products
Sanofi Pasteur
Chengdu Institute of Biological Products
GlaxoSmithKline
Lanzhou Institute of Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Biken
Market size by Product
By strain
Nakayama
Beijing
P-3
SA 14-14-2
By type
Mouse Brain-Derived, Inactivated Vaccine
Cell Culture-Derived, Inactivated Vaccine
Cell Culture-Derived, Live Attenuated Vaccine
Market size by End User
Child
Adult
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Encephalitis Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Encephalitis Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Encephalitis Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Encephalitis Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Encephalitis Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Encephalitis Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Encephalitis Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Encephalitis Vaccine Market Size Growth Rate by Product
- 1.4.2 Nakayama
- 1.4.3 Beijing
- 1.4.4 P-3
- 1.4.5 SA 14-14-2
- 1.5 Market by End User
- 1.5.1 Global Encephalitis Vaccine Market Size Growth Rate by End User
- 1.5.2 Child
- 1.5.3 Adult
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Encephalitis Vaccine Market Size
- 2.1.1 Global Encephalitis Vaccine Revenue 2014-2025
- 2.1.2 Global Encephalitis Vaccine Sales 2014-2025
- 2.2 Encephalitis Vaccine Growth Rate by Regions
- 2.2.1 Global Encephalitis Vaccine Sales by Regions
- 2.2.2 Global Encephalitis Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Encephalitis Vaccine Sales by Manufacturers
- 3.1.1 Encephalitis Vaccine Sales by Manufacturers
- 3.1.2 Encephalitis Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Encephalitis Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Encephalitis Vaccine Revenue by Manufacturers
- 3.2.1 Encephalitis Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Encephalitis Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Encephalitis Vaccine Price by Manufacturers
- 3.4 Encephalitis Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Encephalitis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Encephalitis Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Encephalitis Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Encephalitis Vaccine Sales by Product
- 4.2 Global Encephalitis Vaccine Revenue by Product
- 4.3 Encephalitis Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Encephalitis Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Encephalitis Vaccine by Countries
- 6.1.1 North America Encephalitis Vaccine Sales by Countries
- 6.1.2 North America Encephalitis Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Encephalitis Vaccine by Product
- 6.3 North America Encephalitis Vaccine by End User
7 Europe
- 7.1 Europe Encephalitis Vaccine by Countries
- 7.1.1 Europe Encephalitis Vaccine Sales by Countries
- 7.1.2 Europe Encephalitis Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Encephalitis Vaccine by Product
- 7.3 Europe Encephalitis Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Encephalitis Vaccine by Countries
- 8.1.1 Asia Pacific Encephalitis Vaccine Sales by Countries
- 8.1.2 Asia Pacific Encephalitis Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Encephalitis Vaccine by Product
- 8.3 Asia Pacific Encephalitis Vaccine by End User
9 Central & South America
- 9.1 Central & South America Encephalitis Vaccine by Countries
- 9.1.1 Central & South America Encephalitis Vaccine Sales by Countries
- 9.1.2 Central & South America Encephalitis Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Encephalitis Vaccine by Product
- 9.3 Central & South America Encephalitis Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Encephalitis Vaccine by Countries
- 10.1.1 Middle East and Africa Encephalitis Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Encephalitis Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Encephalitis Vaccine by Product
- 10.3 Middle East and Africa Encephalitis Vaccine by End User
11 Company Profiles
- 11.1 Liaoning Chengda
- 11.1.1 Liaoning Chengda Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Liaoning Chengda Encephalitis Vaccine Products Offered
- 11.1.5 Liaoning Chengda Recent Development
- 11.2 Wuhan Institute of Biological
- 11.2.1 Wuhan Institute of Biological Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Wuhan Institute of Biological Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Wuhan Institute of Biological Encephalitis Vaccine Products Offered
- 11.2.5 Wuhan Institute of Biological Recent Development
- 11.3 Valneva
- 11.3.1 Valneva Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Valneva Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Valneva Encephalitis Vaccine Products Offered
- 11.3.5 Valneva Recent Development
- 11.4 Tiantan Biological Products
- 11.4.1 Tiantan Biological Products Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Tiantan Biological Products Encephalitis Vaccine Products Offered
- 11.4.5 Tiantan Biological Products Recent Development
- 11.5 Sanofi Pasteur
- 11.5.1 Sanofi Pasteur Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sanofi Pasteur Encephalitis Vaccine Products Offered
- 11.5.5 Sanofi Pasteur Recent Development
- 11.6 Chengdu Institute of Biological Products
- 11.6.1 Chengdu Institute of Biological Products Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Chengdu Institute of Biological Products Encephalitis Vaccine Products Offered
- 11.6.5 Chengdu Institute of Biological Products Recent Development
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline Encephalitis Vaccine Products Offered
- 11.7.5 GlaxoSmithKline Recent Development
- 11.8 Lanzhou Institute of Biological Products
- 11.8.1 Lanzhou Institute of Biological Products Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Products Offered
- 11.8.5 Lanzhou Institute of Biological Products Recent Development
- 11.9 Zhejiang Tianyuan Bio-Pharmaceutical
- 11.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Products Offered
- 11.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
- 11.10 Biken
- 11.10.1 Biken Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Biken Encephalitis Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Biken Encephalitis Vaccine Products Offered
- 11.10.5 Biken Recent Development
12 Future Forecast
- 12.1 Encephalitis Vaccine Market Forecast by Regions
- 12.1.1 Global Encephalitis Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Encephalitis Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Encephalitis Vaccine Market Forecast by Product
- 12.2.1 Global Encephalitis Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Encephalitis Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Encephalitis Vaccine Market Forecast by End User
- 12.4 North America Encephalitis Vaccine Forecast
- 12.5 Europe Encephalitis Vaccine Forecast
- 12.6 Asia Pacific Encephalitis Vaccine Forecast
- 12.7 Central & South America Encephalitis Vaccine Forecast
- 12.8 Middle East and Africa Encephalitis Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Encephalitis Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Encephalitis Vaccine . Industry analysis & Market Report on Encephalitis Vaccine is a syndicated market report, published as Global Encephalitis Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Encephalitis Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
